1 active not recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Colette Shen: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases Olaparib, Stereotactic Radiosurgery, Durvalumab - Breast Cancer, Brain Metastases, Adult | Phase 1 / Phase 2 | Active not recruiting | Colette Shen | 41 | 2022-03-09 | 2026-07-10 |
Brain Neoplasms (1) · Breast Neoplasms (1)
130-nm albumin-bound paclitaxel (1) · Capecitabine (1) · Carboplatin (1) · Cisplatin (1) · Gemcitabine (1) · Paclitaxel (1) · Radiosurgery (1) · durvalumab (1) · eribulin (1) · olaparib (1)
United States (1)